GDF9 anticorps (AA 320-454) (HRP)

N° du produit ABIN7154561

Détail du produit anti-GDF9 anticorps (HRP)

Antigène: GDF9 (Growth Differentiation Factor 9 (GDF9))

Épitope: AA 320-454

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp GDF9 est conjugé à/à la HRP

Application: ELISA

Réactivité croisée: Humain

Purification: >95%, Protein G purified

Immunogène: Recombinant Human Growth/differentiation factor 9 protein (320-454AA)

Isotype: IgG

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur GDF9

Antigène: GDF9 (Growth Differentiation Factor 9 (GDF9))

Autre désignation: GDF9 (GDF9 Produits)

Synonymes: anticorps GDF-9, anticorps zgc:123030, anticorps Gdf-9, anticorps growth differentiation factor 9, anticorps GDF9, anticorps gdf9, anticorps Gdf9

Sujet:

Background: Required for ovarian folliculogenesis. Promotes primordial follicle development. Stimulates granulosa cell proliferation. Promotes cell transition from G0/G1 to S and G2/M phases, through an increase of CCND1 and CCNE1 expression, and RB1 phosphorylation. It regulates STAR expression and cAMP-dependent progesterone release in granulosa and thecal cells. Attenuates the suppressive effects of activin A on STAR expression and progesterone production by increasing the expression of inhibin B. It suppresses FST and FSTL3 production in granulosa-lutein cells.

Aliases: GDF9Growth/differentiation factor 9 antibody, GDF-9 antibody

UniProt: O60383